IMPACT CLL & MCL: IMPlementing Advances in Cancer Treatment for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

CME Education Series

To access individual CME activity information and to participate, please click the participation button above.

Patient Education: Click here to access education for your CLL patients on how to work with their healthcare team.

Target Audience

This educational activity is intended for an audience of hematologists/oncologists, members of the oncology multidisciplinary team (MDT; nurses, nurse practitioners, pharmacists, physician assistants), and other clinicians who care for patients with CLL or MCL globally, excluding the United Kingdom.

Description

The evolving treatment landscape of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) is evolving with novel therapies that may overcome the challenges of resistance and disease progression. Our initiative, IMPACT CLL and MCL, leverages the latest clinical advancements and patient-centric strategies to improve treatment outcomes. The goal of this activity is for learners to be better able to implement a coordinated, multidisciplinary approach in managing patients with CLL and MCL, integrate current treatment strategies, and manage adverse events effectively to improve patient outcomes.

Activity Topics

Chronic Lymphocytic Leukemia Case Simulation: Put Your Skills to the Test
Collaborative Care: Navigating Multidisciplinary Management of CLL and MCL for Optimal Patient Outcomes

Providers

This activity is developed through a collaboration between The Leukemia & Lymphoma Society and Medscape Oncology.

Supporters

This activity is supported by an independent educational grant from Lilly.

For questions, concerns, or assistance for people with disabilities or grievances, please contact LLS at: [email protected].